ElevateBio logo

ElevateBio

A cell and gene therapy company accelerating access to technologies and expertise to change the future of medicine.

494 employees · est. 2021 · Waltham, United States

VS
Noema Pharma logo

Noema Pharma

A clinical-stage biotech pioneering a portfolio of disease-transforming therapeutics for CNS-mediated conditions

33 employees · est. 2019 · Basel, Switzerland

Noema Pharma is the older company (2021 vs 2019); ElevateBio is the larger of the two.

Side-by-Side Comparison

ElevateBio Noema Pharma
Founded
2021 2019 older
Headquarters
Waltham, United States Basel, Switzerland
Employees
494 larger 33
Industry
Biotechnology Biotechnology, Pharmaceutical
Funding Stage
Series D Series B
Total Funding
$1.25B $184.00M
Funding Rounds
5 3
Services
Not tracked yet Development of oral small molecule therapeutics, Advancement of clinical-stage programs, Strategic collaborations with investors and partners, Educational resource provision for patients
Target Customers
Not tracked yet Patients with neurological disorders, Individuals experiencing menopause-related symptoms, Healthcare providers, Investors interested in biotech and pharmaceutical innovations
Taxonomy
Cell And Gene Therapy, Technology-driven Company, Innovation, Commercialization, Gene Editing, Induced Pluripotent Stem Cells (iPSCs), Protein Engineering, Vector Engineering, Cellular Engineering, Manufacturing Platform, Process Innovation, Drug Development, Collaborations Biotech, Clinical-stage, Therapeutics Development, CNS-mediated Conditions, Orphan Brain Disorders, Neurological Diseases, Patient-centered Research, Novel Therapies, Symptom Management, R&D
Website
elevate.bio noemapharma.com
ElevateBio logo

About ElevateBio

ElevateBio is a biotechnology startup that aims to revolutionize medicine by accelerating access to cutting-edge cell and gene therapy technologies. The company, founded in 2021 and headquartered in the United States, has quickly gained attention in the industry. ElevateBio boasts a robust team of i...

Noema Pharma logo

About Noema Pharma

Noema Pharma, founded in 2019, is a promising clinical-stage biotech company headquartered in Switzerland. The company’s mission is captured in its slogan: "A clinical-stage biotech pioneering a portfolio of disease-transforming therapeutics for CNS-mediated conditions." They are on the frontier of...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at ElevateBio and Noema Pharma — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at ElevateBio and Noema Pharma — by email.

Frequently Asked Questions

ElevateBio — A cell and gene therapy company accelerating access to technologies and expertise to change the future of medicine.. Noema Pharma — A clinical-stage biotech pioneering a portfolio of disease-transforming therapeutics for CNS-mediated conditions. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
ElevateBio has raised $1.25B while Noema Pharma has raised $184.00M.
ElevateBio and Noema Pharma operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare ElevateBio with someone else

Start typing a company name or domain.

One analytics cookie (Google Analytics). Cookie Policy